We are live on ! Find out more
STJ

St Jude Medical
STJ

Delisted

STJ was delisted on the 4th of January, 2017.

591 hedge funds and large institutions have $16.1B invested in St Jude Medical in 2014 Q4 according to their latest regulatory filings, with 79 funds opening new positions, 187 increasing their positions, 229 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

181% more call options, than puts

Call options by funds: $172M | Put options by funds: $61M

84% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 43

60% more funds holding in top 10

Funds holding in top 10: 58 (+3)

5% more capital invested

Capital invested by funds: $15.3B → $16.1B (+$804M)

5% more funds holding

Funds holding: 563591 (+28)

18% less repeat investments, than reductions

Existing positions increased: 187 | Existing positions reduced: 229

Holders
591
Holders Change
+28
Holders Change %
+4.97%
% of All Funds
15.76%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.21%
New
79
Increased
187
Reduced
229
Closed
43
Calls
$172M
Puts
$61M
Net Calls
+$110M
Net Calls Change
+$94.9M
Name Holding Trade Value Shares
Change
Change in
Stake
PDN
276
Pensionfund DSM Netherlands
Netherlands
$1.94M
HighTower Advisors
277
HighTower Advisors
Illinois
$1.91M +$647K +10,047 +52%
CSS
278
Cubist Systematic Strategies
Connecticut
$1.84M -$225K -3,487 -11%
FHC
279
First Houston Capital
Texas
$1.84M +$200K +3,100 +12%
CIBC Asset Management
280
CIBC Asset Management
Ontario, Canada
$1.84M -$570K -8,845 -24%
GAM
281
Griffin Asset Management
New York
$1.82M -$9.21K -143 -0.5%
LCM
282
Laurion Capital Management
New York
$1.82M +$1.8M +28,000 New
RJT
283
Raymond James Trust
Florida
$1.8M +$1.48K +23 +0.1%
JGUA
284
John G. Ullman & Associates
New York
$1.79M -$33.8K -525 -2%
NLI
285
Nippon Life Insurance
Japan
$1.74M -$261K -4,047 -13%
CBOA
286
Commonwealth Bank of Australia
Australia
$1.73M -$424K -6,580 -20%
TAM
287
Tocqueville Asset Management
New York
$1.72M -$194K -3,017 -10%
SAM
288
Securian Asset Management
Minnesota
$1.68M +$51.8K +804 +3%
FNT
289
First National Trust
Pennsylvania
$1.63M -$283K -4,391 -15%
FAM
290
Fiduciary Asset Management
Missouri
$1.63M +$1.61M +25,000 New
B
291
Barings
North Carolina
$1.61M
Calamos Advisors
292
Calamos Advisors
Illinois
$1.6M +$8.24K +128 +0.5%
MAM
293
Mizuho Asset Management
Japan
$1.59M +$565K +8,774 +56%
SMDAM
294
Sumitomo Mitsui DS Asset Management
Japan
$1.58M -$152K -2,362 -9%
Creative Planning
295
Creative Planning
Kansas
$1.56M +$150K +2,328 +11%
Nomura Holdings
296
Nomura Holdings
Japan
$1.51M +$1.26M +19,589 +553%
Mackenzie Financial
297
Mackenzie Financial
Ontario, Canada
$1.5M -$535K -8,314 -26%
CA
298
Cullinan Associates
Kentucky
$1.44M +$419K +6,500 +42%
DIA
299
Dana Investment Advisors
Wisconsin
$1.41M +$462K +7,173 +49%
NC
300
Northpointe Capital
Michigan
$1.4M -$19.9K -309 -1%

STJ Hedge Fund Activity: Q4 2014 in Review

591 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in St Jude Medical (STJ) for Q4 2014, worth a combined $16.1B — up 5.3% from $15.3B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new STJ positions and 43 closed out — a net gain of 36 holders — while 187 added to existing stakes and 229 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $181M. The largest seller was Americafirst Capital Management, exiting entirely with an estimated $699M sold.

  • 591 institutional investors held St Jude Medical (STJ) as of Q4 2014, up from 563 in Q3 2014.
  • Funds reported $16.1B of St Jude Medical stock for Q4 2014, up 5.3% quarter-over-quarter.
  • 79 funds opened new St Jude Medical positions in Q4 2014 and 43 closed out, a net change of +36 holders.
  • The largest St Jude Medical buyer in Q4 2014 was Capital Research Global Investors, an estimated $181M added.
  • The largest St Jude Medical seller in Q4 2014 was Americafirst Capital Management, an estimated $699M sold.

Based on aggregated 13F filings for Q4 2014.